New Jersey Bariatric Center
sign in
November 8, 2023
FDA Approves Prescription Weight Loss Injection Zepbound™

Studies show weight loss injection can decrease total body weight by more than 20% November 8th, 2023: Today the FDA approved Zepbound™, Eli Lilly’s prescription weight loss injection. Zepbound™ is a weekly, self-administered injection used for the treatment of chronic weight management in adults with obesity. Tirzepatide, the active ingredient in Zepbound™ works by altering […]

Read More
June 30, 2023
New Jersey Bariatric Center Surgeons Present New Data on the Safety and Efficacy of Gastric Sleeve and Gastric Bypass with Low BMI Surgery

A significant health benefit of gastric sleeve and gastric bypass surgery is the control of and in some cases resolution of many severe weight-related medical conditions such as diabetes, hypertension and sleep apnea. Knowing the significant health impact these procedures can have on individuals living with obesity, the surgeons at NJBC set out to demonstrate […]

Read More
February 14, 2023
New Cleveland Clinic Study: Bariatric Surgery and Lower Mortality Rates of Heart Attack Patients

Heart attack is the leading cause of death in the US, and obesity is one of the main risk factors. A study by the Cleveland Clinic analyzed the data of almost 300,000 patients with obesity and the results showed  lower rates of mortality and complications1 among patients who suffered a heart attack with a history […]

Read More
November 30, 2022
New Jersey Bariatric Center® Opens New Location in Totowa, NJ

Office to Serve Gastric Sleeve and Gastric Bypass Patients in Passaic County SPRINGFIELD, N.J., November 30, 2022 – New Jersey Bariatric Center® (NJBC), an industry leader in medical and surgical weight loss, is announcing a new office location in northeastern New Jersey to serve its growing patient base. Located in Totowa, NJ, this is NJBC’s […]

Read More
July 8, 2022
New Jersey Bariatric Center Offers Robotic Assisted Bariatric Surgery

In the early days of bariatric surgery procedures were done by creating one large open incision in the abdomen. That method has since evolved and the majority of surgeries are being performed laparoscopically through about five small incisions in the abdomen which have led to less pain and faster recovery. Recently, a technologically advanced method […]

Read More
February 2, 2022
Can Weight Loss Surgery Help with Acid Reflux?

Acid reflux, also known as gastroesophageal reflux disease (GERD), affects more than 20% of adults. It occurs when the acid in your stomach “backs up” into the esophagus, causing a burning sensation in your chest. Other symptoms may include nausea, pain/difficulty swallowing, cough and bad breath. The first line of treatment often involves long term […]

Read More
June 24, 2021
NJBC Now Offering FDA-Approved Prescription Weight Loss Injection Wegovy™

New Jersey Bariatric Center now offers Wegovy™, the FDA-approved prescription weight loss injection. Wegovy™ is a weekly, self-administered injection used for the treatment of chronic weight management in adults with obesity. Wegovy™ works by mimicking a hormone that targets the area of your brain that regulates appetite, with studies showing that the drug helped people […]

Read More
June 18, 2021
A Second Chance at Weight Loss: Revision Surgery Webinar

For some patients, bariatric surgery is the jump start they need to lose and sustain weight loss. But for others, sometimes, no matter how hard you work, life’s circumstances get in the way and you need a second chance.  The stressors of life, old eating habits and now a global pandemic can make the journey […]

Read More
April 7, 2021
Scheduling Surgery and the COVID-19 Vaccine

As more vaccination appointments become available, patients have been asking what to do if their vaccine appointment is near their weight loss surgery or general surgery date.  If you have a COVID-19 vaccine appointment, whether first or second dose, near your surgery date we recommend it be 7 days before or 7 days after your […]

Read More
February 24, 2021
Obesity Now a Criteria for COVID-19 Vaccine Eligibility in NJ

The state of New Jersey has announced that individuals at high risk of severe COVID-19 complications,including those with obesity, severe obesity and medical conditions such as Type 2 diabetes, are eligible for the COVID-19 vaccine. Obesity is classified as having a body mass index (BMI) of 30 or higher but less than 40, and severe […]

Read More
June 19, 2020
Update: Telemedicine & In-Office Appointments

[vc_row][vc_column][vc_column_text]NJBC continues to take the necessary steps to help limit the spread of the Covid virus to our patients, staff and the communities we serve. We are continuing telemedicine appointments and offering a limited number of in-person appointments. To schedule an appointment, call our office at 908-481-1270 or to request a call, click here. What […]

Read More
March 22, 2020
New Jersey Bariatric Center moves to Telemedicine

Telemedicine now available at NJBC In our effort to help stop the spread of COVID-19 and accommodate our patient’s needs, New Jersey Bariatric Center now offers telemedicine appointments. Scheduling a Telemedicine Appointment Call our office at 908-481-1270 or click here to schedule a telemedicine appointment. After scheduling, patients will receive a confirmation email from us […]

Read More
1 2 3 4
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram